Fifth Third Bancorp Sells 2,149 Shares of Agilent Technologies, Inc. $A

Key Points

• Fifth Third Bancorp reduced its stake in Agilent Technologies by 8.1%, selling 2,149 shares and now holding 24,279 shares worth approximately $2.87 million.
• Agilent Technologies reported $1.74 billion in quarterly revenue, exceeding analyst expectations, while earnings per share (EPS) met consensus estimates at $1.37.
• The company declared a quarterly dividend of $0.248 per share, with a dividend yield of 0.8%, payable on October 22nd.

Fifth Third Bancorp decreased its position in Agilent Technologies, Inc. (NYSE:A - Free Report) by 8.1% during the 2nd quarter, according to its most recent disclosure with the SEC. The fund owned 24,279 shares of the medical research company's stock after selling 2,149 shares during the period. Fifth Third Bancorp's holdings in Agilent Technologies were worth $2,865,000 as of its most recent SEC filing.

Several other institutional investors and hedge funds have also recently made changes to their positions in the company. Vanguard Group Inc. grew its holdings in shares of Agilent Technologies by 0.7% in the first quarter. Vanguard Group Inc. now owns 33,408,626 shares of the medical research company's stock worth $3,908,141,000 after purchasing an additional 240,965 shares during the last quarter. Pictet Asset Management Holding SA grew its holdings in shares of Agilent Technologies by 2.5% in the first quarter. Pictet Asset Management Holding SA now owns 5,341,870 shares of the medical research company's stock worth $624,888,000 after purchasing an additional 128,131 shares during the last quarter. Generation Investment Management LLP grew its holdings in shares of Agilent Technologies by 19.8% in the first quarter. Generation Investment Management LLP now owns 4,983,556 shares of the medical research company's stock worth $582,976,000 after purchasing an additional 824,243 shares during the last quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC grew its holdings in shares of Agilent Technologies by 18.7% in the first quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC now owns 3,836,105 shares of the medical research company's stock worth $448,748,000 after purchasing an additional 604,124 shares during the last quarter. Finally, Impax Asset Management Group plc boosted its holdings in Agilent Technologies by 3.6% in the first quarter. Impax Asset Management Group plc now owns 2,931,794 shares of the medical research company's stock valued at $342,961,000 after acquiring an additional 102,365 shares in the last quarter.

Agilent Technologies Stock Performance

Shares of Agilent Technologies stock opened at $123.45 on Friday. The company has a current ratio of 2.25, a quick ratio of 1.71 and a debt-to-equity ratio of 0.53. The firm has a market capitalization of $35.00 billion, a P/E ratio of 28.98, a P/E/G ratio of 3.98 and a beta of 1.24. The business has a fifty day simple moving average of $121.15 and a two-hundred day simple moving average of $115.95. Agilent Technologies, Inc. has a 12 month low of $96.43 and a 12 month high of $153.84.

Agilent Technologies (NYSE:A - Get Free Report) last announced its quarterly earnings data on Wednesday, August 27th. The medical research company reported $1.37 EPS for the quarter, meeting the consensus estimate of $1.37. The business had revenue of $1.74 billion during the quarter, compared to analyst estimates of $1.67 billion. Agilent Technologies had a return on equity of 25.51% and a net margin of 17.97%.The company's revenue for the quarter was up 10.1% on a year-over-year basis. During the same quarter last year, the firm posted $1.32 earnings per share. Agilent Technologies has set its FY 2025 guidance at 5.560-5.590 EPS. Q4 2025 guidance at 1.570-1.600 EPS. On average, equities analysts forecast that Agilent Technologies, Inc. will post 5.58 earnings per share for the current fiscal year.

Agilent Technologies Dividend Announcement

The business also recently declared a quarterly dividend, which will be paid on Wednesday, October 22nd. Stockholders of record on Tuesday, September 30th will be given a $0.248 dividend. This represents a $0.99 annualized dividend and a dividend yield of 0.8%. The ex-dividend date of this dividend is Tuesday, September 30th. Agilent Technologies's payout ratio is currently 23.24%.

Analyst Ratings Changes

Several analysts recently weighed in on A shares. Wall Street Zen cut shares of Agilent Technologies from a "buy" rating to a "hold" rating in a report on Friday, September 5th. Evercore ISI cut their price target on shares of Agilent Technologies from $130.00 to $128.00 and set an "in-line" rating on the stock in a report on Thursday, August 28th. Leerink Partners lifted their price target on shares of Agilent Technologies to $135.00 and gave the company a "buy" rating in a report on Friday, May 30th. Barclays reiterated an "equal weight" rating and issued a $125.00 price target on shares of Agilent Technologies in a report on Friday, August 29th. Finally, Wells Fargo & Company lifted their price target on shares of Agilent Technologies from $140.00 to $150.00 and gave the company an "overweight" rating in a report on Monday, September 15th. Six investment analysts have rated the stock with a Buy rating and six have assigned a Hold rating to the company. According to MarketBeat.com, Agilent Technologies presently has an average rating of "Moderate Buy" and an average price target of $140.08.

Insider Activity

In other news, CEO Padraig Mcdonnell sold 1,508 shares of Agilent Technologies stock in a transaction dated Tuesday, July 1st. The stock was sold at an average price of $117.44, for a total value of $177,099.52. Following the completion of the transaction, the chief executive officer owned 37,448 shares of the company's stock, valued at $4,397,893.12. The trade was a 3.87% decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website.

About Agilent Technologies

Agilent Technologies, Inc provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide. The company operates in three segments: Life Sciences and Applied Markets, Diagnostics and Genomics, and Agilent CrossLab. The Life Sciences and Applied Markets segment offers liquid chromatography systems and components; liquid chromatography mass spectrometry systems; gas chromatography systems and components; gas chromatography mass spectrometry systems; inductively coupled plasma mass spectrometry instruments; atomic absorption instruments; microwave plasma-atomic emission spectrometry instruments; inductively coupled plasma optical emission spectrometry instruments; raman spectroscopy; cell analysis plate based assays; flow cytometer; real-time cell analyzer; cell imaging systems; microplate reader; laboratory software; information management and analytics; laboratory automation and robotic systems; dissolution testing; and vacuum pumps, and measurement technologies.

Want to see what other hedge funds are holding A? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Agilent Technologies, Inc. (NYSE:A - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.